Health
AHA: New Medication, Finerenone, Helps Heart Health in People With Chronic Kidney Disease, Type 2 Diabetes – Cath Lab Digest
DALLAS, Nov. 17, 2020 — The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events…
DALLAS, Nov. 17, 2020 — The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented at the American Heart Association’s Scientific Sessions 2020. The virtual meeting is Friday, November 13-Tuesday, November 17, 2020, and is a premier global exchange of the latest scientific advancements, research and evidence-based…
-
Noosa News10 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News11 hours agoMotorcyclist dies in crash with truck
-
Noosa News11 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General16 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging